Cellular and Molecular Neurobiology

, Volume 27, Issue 8, pp 1085–1095 | Cite as

Enhanced [3H] Glutamate Binding in the Cerebellum of Insulin-Induced Hypoglycaemic and Streptozotocin-Induced Diabetic Rats

  • Anu Joseph
  • Remya Robinson
  • C. S. Paulose
Original Paper


Aim Energy deprivation causes neuronal death affecting the cognitive and memory ability of an individual. The kinetic parameters of glutamate dehydrogenase (GDH), the enzyme involved in the production of glutamate, was studied in the cerebellum and liver and the binding parameters of glutamate receptors in the cerebellum of insulin-induced hypoglycaemic and streptozotocin-induced diabetic rats were studied to reveal the role of glutamate excitotoxicity. Methods A single intrafemoral dose of streptozotocin was administered to induce diabetes. Hypoglycaemia was induced by appropriate doses of insulin subcutaneously in control and diabetic rats. The kinetic parameters Vmax and Km of GDH were studied spectrophotometrically at different substrate concentrations of α-ketoglutarate. Glutamate receptor binding assay was done with different concentrations of [3H] Glutamate. Results The GDH enzyme assay showed a significant increase (P < 0.001) in the Vmax of the enzyme in the cerebellum of hypoglycaemic and diabetic rat groups when compared to control. The Vmax of hypoglycaemic groups was significantly increased (P < 0.001) when compared to diabetic group. In the liver, the Vmax of GDH was significantly increased (P < 0.001) in the diabetic and diabetic hypoglycaemia group when compared to control. The Vmax of GDH increased significantly (P < 0.001) in the diabetic hypoglycaemic rats compared to diabetic group, whereas the control hypoglycaemic rats showed a significant decrease in Vmax (P < 0.001) when compared to diabetic and diabetic hypoglycaemic rats. The Km showed no significant change amongst the groups in cerebellum and liver. Scatchard analysis showed a significant increase (P < 0.001) in Bmax in the cerebellum of hypoglycaemic and diabetic rats when compared to control. The Bmax of hypoglycaemic rats significantly increased (P < 0.001) when compared to diabetic group. In hypoglycaemic groups, Bmax of the control hypoglycaemic rats showed a significant increase (P < 0.001) compared to diabetic hypoglycaemic rats. The Kd of the diabetic group decreased significantly (P < 0.01) when compared to control and control hypoglycaemic rats. There was a significant decrease (P < 0.05) in the Kd of diabetic hypoglycaemic group when compared to the control hypoglycaemic rats. Conclusion Our studies demonstrated the increased enzyme activity in the hypoglycaemic rats with increased production of extracellular glutamate. The present study also revealed increased binding parameters of glutamate receptors reflecting an increased receptor number with increase in the affinity. This increased number of receptors and the increased glutamate production will lead to glutamate excitotoxicity and neuronal degeneration which has an impact on the cognitive and memory ability. This has immense clinical significance in the management of diabetes and insulin therapy.


Hypoglycaemia Diabetes Glutamate dehydrogenase Glutamate receptors Cerebellum Liver 



Dr. C. S. Paulose thanks DBT, DST, ICMR. Govt. of India and KSCSTE, Govt. of Kerala for the financial assistance. Remya Robinson thanks Cochin University For JRF.


  1. Aral YZ, Gucuyener K, Atalay Y, Hasanoglu A, Turkyilmaz C, Sayal A, Biberoglu G (1998) Role of excitatory aminoacids in neonatal hypoglycemia. Acta Paediatr Jpn 40:303–306PubMedGoogle Scholar
  2. Arison RN, Ciaccio EI, Glitzer MS, Cassaro JA, Pruss MP (1967) Light and electron microscopy of lesions in rats rendered diabetic with streptozotocin. Diabetes 16:51–56PubMedGoogle Scholar
  3. Aswathy RN, Biju MP, Paulose CS (1998) Effect of pyridoxine and insulin administration on brain glutamate dehydrogenase activity and blood glucose control in streptozotocin-induced diabetic rats. Biochim Biophys Acta 1381:351–354Google Scholar
  4. Atlante A, Gagliardi S, Minervini GM, Ciotti MT, Marra E, Calissano P (1997) Glutamate neurotoxicity in rat cerebellar granule cells: a major role for xanthine oxidase in oxygen radical formation. J Neurochem 68:2038–2045PubMedCrossRefGoogle Scholar
  5. Auer RN (1991) Excitotoxic mechanisms, and age-related susceptibility to brain damage in ischemia, hypoglycemia and toxic mussel poisoning. Neurotoxicology 12:541–546PubMedGoogle Scholar
  6. Auer RN, Siesjo BK (1993) Hypoglycaemia: brain neurochemistry and neuropathology. Baillieres Clin Endocrinol Metab 7:611–625PubMedCrossRefGoogle Scholar
  7. Beaufay H, Bendall DS, Baudhuin P, de Duve C (1959) Tissue fractionation studies. 12. Intracellular distribution of some dehydrogenases, alkaline deoxyribonuclease and iron in rat-liver tissue. Biochem J 73:623–628PubMedGoogle Scholar
  8. Beckman JS, Koppenol WH (1996) Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271:C1424–C1437PubMedGoogle Scholar
  9. Berman FW, Murray TF (1996) Characterization of [3H]MK-801 binding to N-methyl-d-aspartate receptors in cultured rat cerebellar granule neurons and involvement in glutamate-mediated toxicity. J Biochem Toxicol 11:217–226PubMedCrossRefGoogle Scholar
  10. Biju MP, Paulose CS (1998) Brain glutamate dehydrogenase changes in streptozotocin diabetic rats as a function of age. Biochem Mol Biol Int 44:1–7PubMedGoogle Scholar
  11. Bindokas VP, Jordan J, Lee CC, Miller RJ (1996) Superoxide production in rat hippocampal neurons: selective imaging with hydroethidine. J Neurosci 16:1324–1336PubMedGoogle Scholar
  12. Blattner RJ (1968) Central nervous system damage and hypoglycemia. J Pediatr 72:904–906PubMedCrossRefGoogle Scholar
  13. Budd SL, Nicholas DG (1996) Mitochondria, calcium regulation, and acute glutamate excitotoxicity in cultured cerebellar granule cells. J Neurochem 67:2282–2291PubMedCrossRefGoogle Scholar
  14. Cavaliere F, D’Ambrosi N, Sancesario G, Bernardi G, Volonte C (2001) Hypoglycaemia-induced cell death: features of neuroprotection by the P2 receptor antagonist basilen blue. Neurochem Int 38:199–207PubMedCrossRefGoogle Scholar
  15. Choi DW (1988) Glutamate neurotoxicity and diseases of nervous system. Neuron 1:623–634PubMedCrossRefGoogle Scholar
  16. Christie GS, Judah JD (1953) Intracellular distribution of enzymes. Proc R Soc Lond Biol Sci 141:420–433CrossRefGoogle Scholar
  17. di Prisco G, Harold JS (1970) Glutamate dehydrogenase of nuclear and extra-nuclear compartments of Chang’s liver cells. Eur J Biochem 12:483–489PubMedCrossRefGoogle Scholar
  18. di Prisco G, Banay-Schwartz M, Strecker HJ (1968) Glutamate dehydrogenase in nuclear and mitochondrial fractions of rat liver. Biochem Biophys Res Commun 33:606–612PubMedCrossRefGoogle Scholar
  19. Flanagan DE, Evans ML, Monsod TP, Rife F, Heptulla RA, Tamborlane WV, Sherwin RS (2003) The influence of insulin on circulating ghrelin. Am J Physiol Endocrinol Metab 284:E313–E316PubMedGoogle Scholar
  20. Fraser DD, Hoehn K, Weiss S, MacVicar BA (1993) Arachidonic acid inhibits sodium currents and synaptic transmission in cultured striatal neurons. Neuron 11:633–644PubMedCrossRefGoogle Scholar
  21. Frizzell RT, Hendrick GK, Biggers DW, Lacy DB, Donahue DP, Green DR, Carr RK, Williams PE, Stevenson RW, Cherrington AD (1988) Role of gluconeogenesis in sustaining glucose production during hypoglycemia caused by continuous insulin infusion in conscious dogs. Diabetes 37:749–759PubMedCrossRefGoogle Scholar
  22. Glowinski J, Iversen LL (1966) Regional studies of catecholamines in the rat brain. The disposition of [3H] norepinephrine, [3H] dopamine and [3H] dopa in various regions of the brain. J Neurochem 13:655–669PubMedCrossRefGoogle Scholar
  23. Greenfield PC, Boell EJ (2005) Malate dehydrogenases and glutamate dehydrogenase in chick liver and heart during embryonic development. J Exp Zool 174:115–123CrossRefGoogle Scholar
  24. Gyan K, Kanungo MS (1970) Alterations in glutamate dehydrogenase of the brain of rats of various ages. Can J Biochem 48:203–206CrossRefGoogle Scholar
  25. Hawdon JM (1999) Hypoglycaemia and the neonatal brain. Eur J Pediatr 158:9–12CrossRefGoogle Scholar
  26. Hogeboom GH, Schneider WC (1953) Intracellular distribution of enzymes. XI. Glutamic dehydrogenase. J Biol Chem 204:233–238PubMedGoogle Scholar
  27. Hohenegger M, Rudas B (1971) Kidney function in experimental diabetic ketosis. Diabetologia 7:334–338PubMedCrossRefGoogle Scholar
  28. Karp MM (1989) Hypoglycemia in diabetes among children and adolescents. Indian J Pediatr 56:93–98CrossRefGoogle Scholar
  29. Kaufman FR (1998) Diabetes in children and adolescents. Areas of controversy. Med Clin North Am 82:721–738PubMedCrossRefGoogle Scholar
  30. Kim M, Zhao-Xue Yu, Bertil BF, Scott AR (2005) Susceptibility of the developing brain to acute hypoglycemia involving A1 adenosine receptor activation. Am J Physiol Endocrinol Metab 289:E562–E569PubMedCrossRefGoogle Scholar
  31. Kishore P, Gabriely I, Cui MH, Di Vito J, Gajavelli S, Hwang JH, Shamoon H (2006) Role of hepatic glycogen breakdown in defective counterregulation of hypoglycemia in intensively treated type 1 diabetes. Diabetes 55:659–666PubMedCrossRefGoogle Scholar
  32. Kostic VS, Mojsilovic LJ, Stojanovic M (1989) Degenerative neuronal disorders associated with deficiency of glutamate dehydrogenase. J Neurol 236:111–114PubMedCrossRefGoogle Scholar
  33. Langan SJ, Deary IJ, Hepburn DA, Frier BM (1991) Cumulative cognitive impairment following recurrent severe hypoglycaemia in adult patients with insulin-treated diabetes mellitus. Diabetologia 34:337–344PubMedCrossRefGoogle Scholar
  34. Lowry OH, Roserbbrough NJ, Farr AL, Randall RJ (1951) Protein measurement with Folin Phenol reagent. J Biol Chem 193:265–275PubMedGoogle Scholar
  35. MacMullen C, Fang J, Hsu BYL, Kelly A, De Lonlay-Debeney P, Saudubray JM, Ganguly A, Smith TJ, Stanley CA (2001) The Hyperinsulinism/hyperammonemia contributing investigators: hyperinsulinism/hyperammonemia syndrome in children with regulatory mutations in the inhibitory guanosine triphosphate binding domain of glutamate dehydrogenase. J Clin Endocrinol Metab 86:1782–1787PubMedCrossRefGoogle Scholar
  36. Magnan C, Laury MC, Adnot P, Doare L, Boucontet L, Kergoat M, Penicaud L, Ktorza A, Gilbert M (1998) Hormonal counterregulation failure in rats is related to previous hyperglycaemia–hyperinsulinaemia. Diabetes Metab 24:46–54PubMedGoogle Scholar
  37. Maran A, Cranston I, Lomas J, Macdonald I, Amiel SA (1994) Protection by lactate of cerebral function during hypoglycaemia. Lancet 343:16–20PubMedCrossRefGoogle Scholar
  38. Marinelli S, Federici M, Giacomini P, Bernardi G, Mercuri NB (2001) Hypoglycemia enhances ionotropic but reduces metabotropic glutamate responses in substantia nigra dopaminergic neurons. J Neurophysiol 85:1159–1166PubMedGoogle Scholar
  39. Mavrothalassitis G, Tzimagiorgis G, Mitsialis A, Zannis V, Plaitakis A, Papamatheakis J, Moschonas N (1988) Isolation and characterization of cDNA clones encoding human liver glutamate dehydrogenase: evidence for a small gene family. Proc Natl Acad Sci 85:3494–3498PubMedCrossRefGoogle Scholar
  40. McCall AL (1992) The impact of diabetes on the CNS. Diabetes 41:557–570PubMedCrossRefGoogle Scholar
  41. McGowan JE, Zanelli SA, HatnFes-Laing AG, Mishra OP, Delivoria-Papadopoulose M (2002) Modification of glutamate binding to sites in newborn brain during hypoglycaemia. Brain Res 927:80–86PubMedCrossRefGoogle Scholar
  42. Miriam K, Mark AD, Elena B, de Rodriguez T, Nicholas GB (1996) Synergy by secretory phospholipase A2 and glutamate on inducing cell death and sustained arachidonic acid metabolic changes in primary cortical neuronal cultures. J Biol Chem 271:32722–32728CrossRefGoogle Scholar
  43. Ng YK, Zeng XX, Ling EA (2004) Expression of glutamate receptors and calcium-binding proteins in the retina of streptozotocin-induced diabetic rats. Brain Res 1018:66–72PubMedCrossRefGoogle Scholar
  44. Novelli A, Reilly JA, Lysko PG, Henneberry RC (1988) Glutamate becomes neurotoxic via the N-methyl-d-aspartate receptors when intracellular energy levels are reduced. Brain Res 451:205–212PubMedCrossRefGoogle Scholar
  45. Ott A, Stolk RP, Van Harskamp F, Pols HAP, Hofman A, Breteler MMB (1999) Diabetes mellitus and the risk of dementia: the Rotterdam Study. Neurology 53:1937–1942PubMedGoogle Scholar
  46. Perry TL, Hansen S (1990) What excititoxin kills striatal neurons in Huntingtons disease? Clues from neurochemical studies. Neurology 40:20–24PubMedGoogle Scholar
  47. Plaitakis A, Berl S, Yahr MD (1984) Neurological disorders associated with deficiency of glutamate dehydrogenase. Ann Neurol 15:144–153PubMedCrossRefGoogle Scholar
  48. Plaitakis AP, Constantakakis E, Smith J (1988) The neuroexcitotoxic amino acids glutamate and aspartate are altered in spinal cord and brain in ALS. Ann Neurol 24:446–449PubMedCrossRefGoogle Scholar
  49. Pomara N, Singh R, Deptula D, Chou JCY, Schwartz MB, LeWitt PA (1992) Glutamate and other CSF amino acids in Alzheimer’s disease. Am J Psychiatry 149:251–254PubMedGoogle Scholar
  50. Preetha N, Padayatti PS, Abraham A, Sudha B, Raghu KG, Paulose CS (1996) Glutamate dehydrogenase induction in the brain of streptozotocin diabetic rats. Indian J Biochem Biophys 33:428–430Google Scholar
  51. Rosenthal MJ, Giampeitro V, Bullmore E, Hopkins D, Evans ML, Andrews CM, Yaguez L, Simmons A, Williams SCR, Amiel SA (1999) Effects of hypoglycemia on brain activation and function in man. In: Fifth international conference on functional mapping of the human brain. Poster No: 279Google Scholar
  52. Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kuncl RW, Kanai Y, Hediger MA, Wang Y, Schielke JP, Welty DF (1996) Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16:675–686PubMedCrossRefGoogle Scholar
  53. Ryan C, Vega A, Drash A (1985) Cognitive deficits in adolescents who developed diabetes early in life. Pediatrics 75:921–927PubMedGoogle Scholar
  54. Sandberg M, Butcher SP, Hagberg H (1986) Extracellular overflow of neuroactive amino acids during severe insulin-induced hypoglycemia: in vivo dialysis of the rat hippocampus. J Neurochem 47:178–184PubMedCrossRefGoogle Scholar
  55. Sang WS, Aoyama K, Chen Y, Garnier P, Matsumori Y, Gum E, Liu J, Swanson RA (2003) Hypoglycemic neuronal death and cognitive impairment are prevented by poly (ADP-ribose) polymerase inhibitors administered after hypoglycemia. J Neurosci 23:10681–10690Google Scholar
  56. Sang WS, Garnier P, Aoyama K, Chen Y, Swanson RA (2004) Zinc release contributes to hypoglycemia-induced neuronal death. Neurobiol Dis 16:538–545CrossRefGoogle Scholar
  57. Sang WS, Aoyama K, Matsumori Y, Liu J, Swanson RA (2005) Pyruvate administered after severe hypoglycemia reduces neuronal death and cognitive impairment. Diabetes 54:1452–1458CrossRefGoogle Scholar
  58. Sang SW, Gum ET, Hamby AM, Chan PH, Swanson RA (2007) Hypoglycaemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase. J Clin Invest 117:910–918CrossRefGoogle Scholar
  59. Scatchard G (1949) The attraction of proteins for small molecules and ions. Ann N Y Acad Sci 51:660–672CrossRefGoogle Scholar
  60. Sokal EM, Trivedi P, Portmann B, Mowat AP (1989) Developmental changes in the intra-acinar distribution of succinate dehydrogenase, glutamate dehydrogenase, glucose-6-phosphatase, and NADPH dehydrogenase in the rat liver. J Pediatr Gastroenterol Nutr 8:522–527PubMedCrossRefGoogle Scholar
  61. Stanley CA, Lieu YK, Hsu BY, Burlina AB, Greenberg CR, Hopwood NJ, Perlman K, Rich BH, Zammarchi E, Poncz M (1998) Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. N Engl J Med 338:1352–1357PubMedCrossRefGoogle Scholar
  62. Stanley CA, Fang J, Kutyna K, Hsu BYL, Ming JE, Glaser B, Poncz M (2000) Molecular basis and characterization of the hyperinsulinism/hyperammonemia syndrome: predominance of mutations in exons 11 and 12 of the glutamate dehydrogenase gene. Diabetes 49:667–673PubMedCrossRefGoogle Scholar
  63. Szabo C, Zingarelli B, O’Connor M, Salzman AL (1996) DNA strand breakage, activation of poly (ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite. Proc Natl Acad Sci USA 93:1753–1758PubMedCrossRefGoogle Scholar
  64. Timothy JG, Young AB, Penny JB (1984) Quantitative autoradiographic distribution of [3H] glutamate binding sites in the rat central nervous system. J Neurosci 4:2133–2144Google Scholar
  65. Tomiyama M, Furusawa K, Kamijo M, Kimura T, Matsunaga M, Baba M (2005) Upregulation of mRNAs coding for AMPA and NMDA receptor subunits and metabotropic glutamate receptors in the dorsal horn of the spinal cord in a rat model of diabetes mellitus. Brain Res Mol Brain Res 20:2750–2781Google Scholar
  66. Trudeau F, Gagnon S, Massicotte G (2004) Hippocampal synaptic plasticity and glutamate receptor regulation: influences of diabetes mellitus. Eur J Pharmacol 14:177–186CrossRefGoogle Scholar
  67. Vannucci RC, Vannucci SJ (2001) Hypoglycemic brain injury. Semin Neonatol 6:147–155PubMedCrossRefGoogle Scholar
  68. Vizi ES (2000) Role of high affinity receptors and membrane transporters in nonsynaptic communication and drug action in the central nervous system. Pharmacol Rev 52:63–89PubMedGoogle Scholar
  69. Widom B, Simonson DC (1994) Iatrogenic hypoglycemia. In: Kahn CR, Weir GC (eds) Joslin’s diabetes mellitus, 13th ed. Lea & Febiger, Philadelphia, pp 489–507Google Scholar
  70. Wieloch T (1985) Hypoglycemia-induced neuronal damage prevented by an N-methyl-d-aspartate antagonist. Science 230:681–683PubMedCrossRefGoogle Scholar
  71. Zhang J, Dawson VL, Dawson TM, Snyder SH (1994) Nitric oxide activation of poly (ADP-ribose) synthetase in neurotoxicity. Science 263:687–689PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  1. 1.Molecular Neurobiology and Cell Biology Unit, Centre for Neuroscience, Department of BiotechnologyCochin University of Science and TechnologyCochinIndia

Personalised recommendations